Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder

被引：0
|
作者：
Van Baardewijk, M
Vis, PM
Einarson, T
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Univ Toronto, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67791-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A209 / A210
页数：2
相关论文
共 50 条
  • [21] COST-UTILITY OF VORTIOXETINE VERSUS VENLAFAXINE XR IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN SOUTH KOREA
    Jung, R.
    Brignone, M.
    Campbell, R.
    Franois, C.
    Milea, D.
    VALUE IN HEALTH, 2015, 18 (03) : A121 - A122
  • [22] Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure
    Ahmed, Ahmed T.
    Biernacka, Joanna M.
    Jenkins, Gregory
    Rush, A. John
    Shinozaki, Gen
    Veldic, Marin
    Kung, Simon
    Bobo, William V.
    Hall-Flavin, Daniel K.
    Weinshilboum, Richard M.
    Wang, Liewei
    Frye, Mark A.
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 246 : 62 - 68
  • [23] Comparative efficacy of sertraline and venlafaxine-XR in major depression
    D'Souza, R
    Sir, A
    de Felice, N
    George, T
    Uguz, S
    Martin, A
    Lamb, W
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S163 - S164
  • [24] ASSOCIATION OF MEDICATION PERSISTENCE AND HEALTH-CARE UTILIZATION IN HIGH-COST PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH DULOXETINE OR VENLAFAXINE XR
    Liu, X.
    Tepper, P.
    Mullins, C. D.
    Faries, D.
    Johnstone, B.
    VALUE IN HEALTH, 2010, 13 (07) : A555 - A555
  • [25] Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases
    Wang, Junling
    Liu, Xianchen
    Mullins, C. Daniel
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (07) : 1303 - 1313
  • [26] Double-blind comparison of escitalopram and venlafaxine XR in the treatment of major depressive disorder
    Bielski, R
    Ventura, D
    Chang, C
    Korotzer, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S263 - S263
  • [27] COMPARISON OF SLEEP OUTCOMES IN GENERALIZED ANXIETY DISORDER FOLLOWING TREATMENT WITH PREGABALIN OR VENLAFAXINE-XR
    Herman, B.
    Mychaskiw, M.
    Mandel, F.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [28] Agomelatine Versus Venlafaxine XR in the Treatment of Anhedonia in Major Depressive Disorder A Pilot Study
    Martinotti, Giovanni
    Sepede, Gianna
    Gambi, Francesco
    Di Iorio, Giuseppe
    De Berardis, Domenico
    Di Nicola, Marco
    Onofrj, Marco
    Janiri, Luigi
    Di Giannantonio, Massimo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 487 - 491
  • [29] Economic evaluation of duloxetine versus serotonin selective reuptake inhibitors and venlafaxine XR in treating major depressive disorder in Scotland
    Benedict, Agnes
    Arellano, Jorge
    De Cock, Erwin
    Baird, Jessamy
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 120 (1-3) : 94 - 104
  • [30] COST-UTILITY ANALYSIS EVALUATING VORTIOXETINE VERSUS VENLAFAXINE XR AND AGOMELATINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TAIWAN
    Brignone, M.
    Atsou, K.
    Reynaud-Mougin, C.
    Chen, W.
    Milea, D.
    VALUE IN HEALTH, 2016, 19 (07) : A841 - A842
12345